Dialogue Health Technologies Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Dialogue Health Tech prevailing Real Value cannot be determined due to lack of data. The current price of Dialogue Health Tech is $0.0. Our model computes the value of Dialogue Health Tech from reviewing the firm fundamentals such as Profit Margin of (0.33) %, current valuation of 78.04 M, and Operating Margin of (0.33) % as well as analyzing its technical indicators and probability of bankruptcy.
Dialogue Health Total Value Analysis
Dialogue Health Technologies is currently anticipated to have takeover price of 78.04 M with market capitalization of 137.33 M, debt of 1.07 M, and cash on hands of 61.06 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Dialogue Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
78.04 M | 137.33 M | 1.07 M | 61.06 M |
Dialogue Health Investor Information
About 15.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.84. Some equities with similar Price to Book (P/B) outperform the market in the long run. Dialogue Health Tech had not issued any dividends in recent years. Dialogue Health Technologies is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Dialogue Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Dialogue Health has an asset utilization ratio of 50.31 percent. This implies that the Company is making $0.5 for each dollar of assets. An increasing asset utilization means that Dialogue Health Technologies is more efficient with each dollar of assets it utilizes for everyday operations.Dialogue Health Ownership Allocation
Dialogue Health holds a total of 66.34 Million outstanding shares. 30% of Dialogue Health Technologies outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Dialogue Health Profitability Analysis
The company reported the revenue of 68.05 M. Net Loss for the year was (251.35 M) with profit before overhead, payroll, taxes, and interest of 28.81 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Dialogue Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Dialogue Health and how it compares across the competition.
Dialogue Health Growth Indicators
Investing in growth stocks can be very risky. If the company such as Dialogue Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 65.8 M | |
| Retained Earnings | -342.9 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Dialogue Pink Sheet
If you are still planning to invest in Dialogue Health Tech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dialogue Health's history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |